Now showing items 1-3 of 3

    • Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease 

      Castelblanco Echavarría, Esmeralda; Sarrias, Maria-Rosa; Betriu i Bars, M. Àngels; Soldevila, Berta; Barranco Altirriba, María; Franch-Nadal, Josep; Valdivielso Revilla, José Manuel; Bermúdez López, Marcelino; Groop, Per-Henrik; Fernández i Giráldez, Elvira; Alonso, Núria; Mauricio Puente, Dídac (Impact Journals, 2021)
      This study assessed the association of CD5L and soluble CD36 (sCD36) with the risk of a cardiovascular event (CVE), including CV death and all-cause mortality in CKD. We evaluated the association of CD5L and sCD36 with a ...
    • Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects 

      Castelblanco Echavarría, Esmeralda; Sanjurjo, Lucía; Falguera, Mireia; Hernández García, Marta; Fernandez-Real, Jose Manuel; Sarrias, Maria-Rosa; Alonso, Núria; Mauricio Puente, Dídac (MDPI, 2019-05)
      The aim of this study was to determine whether plasma concentrations of sCD36 (soluble CD36) are associated with the presence of type 1 or type 2 diabetes. Plasma levels of sCD36 were analysed in 1023 subjects (225 type 1 ...
    • The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus 

      Castelblanco Echavarría, Esmeralda; Sanjurjo, Lucía; Barranco Altirriba, María; Falguera, Mireia; Hernández García, Marta; Soldevila, Berta; Sarrias, Maria-Rosa; Franch-Nadal, Josep; Arroyo, Juan Antonio; Fernandez-Real, Jose Manuel; Alonso, Núria; Mauricio Puente, Dídac (MDPI, 2020)
      This study aimed to determine the association of fatty acid transporter plasma solublecluster of differentiation 36 (sCD36) with subclinical carotid atherosclerosis (SCA). A cross-sectionalstudy was conducted in 1023 ...